-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Downgrades Caribou Biosciences to Sector Perform, Lowers Price Target to $1

Benzinga·10/07/2026 13:48:05
Listen to the news
RBC Capital analyst Luca Issi downgrades Caribou Biosciences (NASDAQ:CRBU) from Outperform to Sector Perform and lowers the price target from $10 to $1.